Education: Return in January

Debate between Nadhim Zahawi and Andrew Murrison

Wednesday 5th January 2022 Commons Chamber

[Nadhim Zahawi]

Why Dyson? Because my civil servants also set up a marketplace for other schools that want to buy air purifiers, and they have looked at what is available in the market and recommended more than just the Dyson brand in that marketplace.

[Dr Andrew Murrison (South West Wiltshire) (Con)]

Happy new year to you, Madam Deputy Speaker. My right hon. Friend’s statement is very much to be welcomed. He is right to point out, however, that masks are not a cost-free option. What evidence does he have about their effectiveness, particularly since the evidence from the US suggests that the effectiveness of masks varies from 98% for an N95 respirator down to about 25% for a three-layer cotton mask? If he is insisting that children wear masks, he is presumably also contemplating the sort of guidance he should issue about the constitution of those masks and how they should be worn to ensure maximum effectiveness at preventing transmission.

[Nadhim Zahawi]

Masks are one of a number of mitigations. The most important mitigation is the vaccine—that is indisputable, whether it is the first two jabs or, now, the booster campaign—and then the testing we are conducting in secondary schools this week, which I have just described, and in other settings as we have guided. I have today published the work we have done on masks, and it has been referred to in the House; I will share that with my right hon. Friend as well. That work is based on an observational study that we conducted in the Department of 123 schools where they rigorously applied the wearing of masks. By the way, we have supplied the masks so that schools have them available and are able to make them available to their students as necessary.

However, in the face of a highly infectious variant, masks are one mitigation that I thought was necessary, based on that observational study and the recommendation from UKHSA, including some of the evidence from places such as Germany and elsewhere. It is something that I did reluctantly, because the challenges around learning are evident as well, and I want to keep them for as short a time as possible, just as we begin to—I hope—get through the bumpiest of the next couple of weeks with omicron.

Covid-19 Update

Debate between Nadhim Zahawi and Andrew Murrison

Monday 6th September 2021 Commons Chamber

[Nadhim Zahawi]

I have grateful for the hon. Lady’s words, including those about the issue of vaccine certification, on which I agree with her. No one in this Government, and certainly not this Prime Minister—as I said at the weekend, it goes against his DNA—wants to curtail people’s freedoms, so we will not do this lightly at the end of September. As for her question about the funding, let me try and give her some more details.

The £5.4 billion cash injection over the next six months in response to covid-19 includes £1 billion to help tackle the backlog, delivering routine surgery and treatments for patients. As I said in my statement, the total Government support for the health service is £34 billion in this year alone. The funding will go towards helping the NHS to manage the immediate pressure of the pandemic. As I have said, it includes an extra £1 billion to help tackle the backlog, along with £2.8 billion to cover related costs such as those of the enhanced infection control measures that are so important to keep staff and patients safe from the virus, and £478 million to continue the hospital discharge programme, freeing up beds.

[Dr Andrew Murrison (South West Wiltshire) (Con)]

Six years ago we lost 28,000 people to seasonal flu. Can the Minister assure me that we will not prioritise the jabbing of 12 to 15-year-olds over the seasonal flu programme, given that the number of children whom we would lose to covid would be vanishingly small in any event? Can he also assure me that in his planning he has considered not only the 15-minute wait that the Pfizer jab requires, but the extra time and effort that are required to get truly informed consent from children whose motivation cannot be clinical, must be altruistic, and may be subject to peer pressure?

[Nadhim Zahawi]

Let me try to unpack my hon. Friend’s question. First, no decision has been made on vaccinating 12 to 15-year-olds who are healthy. We are vaccinating those who are vulnerable. We will not pre-empt the important work that the chief medical officers are doing and on which they are experts. Operationally, we have the infrastructure to be able to deal with both programmes.

The flu and covid booster campaigns are the largest endeavours. As I said earlier, in some weeks we will probably break the record that we set in the original covid vaccination programme. The flu vaccine is traditionally delivered through the brilliant work of GPs and, of course, community pharmacies, and they are doing that again. They have raised their ambition and ordered more than they did last year—which was a record-breaking year—and we have procured centrally as well. I can reassure my hon. Friend that that is our priority. I worry very much about a bad flu season this year, which is why we have been so much more ambitious in that regard, as well as on the covid booster campaign.

Covid-19 Update

Debate between Nadhim Zahawi and Andrew Murrison

Thursday 22nd July 2021 Commons Chamber

[Nadhim Zahawi]

I am grateful for the hon. Member’s question. As I said in answer to the previous question, in public buildings such as this place, and of course in essential travel and essential retail, that will not be applicable. That is very clear.

[Dr Andrew Murrison (South West Wiltshire) (Con) [V]]

Some 22,000 people died from seasonal flu in 2017-18, and the modelling suggests that this year’s season will start early, be severe and affect younger people—a demographic that tends to go to mass events—than covid does. Have the Government also been considering mandating proof of flu vaccination, and can the Minister ensure that vaccination records are transportable between the NHS records of each of the home nations? That is not the case at the moment, to the huge frustration of those seeking second jabs or anticipating the need for the proof of vaccination that he has confirmed today.

Covid-19 Vaccine Update

Debate between Nadhim Zahawi and Andrew Murrison

Thursday 4th February 2021 Commons Chamber

[Nadhim Zahawi]

I am grateful to the hon. Lady for that incredibly important question. Her region has done phenomenally well. I want to praise it because it has 91.8% of first doses for the over-80s in the STP. The NHS is already sharing data with local government. We need to make it more granular. We have brought into the deployment campaign Eleanor Kelly, the former chief executive of Southwark Council, so we are totally in line and integrated with local government, because they know exactly where those hard-to-reach groups are. The hon. Lady raises an incredibly important point and that is a big focus for me.

[Dr Andrew Murrison (South West Wiltshire) (Con) [V]]

The Government have done brilliantly well in securing more than 350 million jabs, which is enough, all being well, to vaccinate the at-risk population several times over. Given the UK’s relatively enlightened and co-operative approach to vaccine roll-out internationally—in sharp contrast to the narrow and vindictive nationalism of certain quarters of the European Union, which really ought to know better—what trigger points and timetable does my hon. Friend envisage for the disbursement of our inventory of surplus jabs, and the infrastructure necessary to deliver them to countries that are less advantaged than our own?

[Nadhim Zahawi]

I am grateful to my right hon. Friend for his excellent question. My absolutely priority is to ensure that we have the inventory—as he quite rightly describes it—to allow us to offer the vaccine to all adults in the United Kingdom, and at the moment we are nowhere near that. Supply remains the limiting factor in our first target, which is to vaccinate groups 1 to 4 by mid-February, and then groups 5 to 9 as soon as we can after that, with phase 2, which we have been discussing today, after that. He is absolutely right that we have now ordered or optioned 407 million doses of vaccine. Once we are in a position to secure enough vaccine for the United Kingdom’s population, we will be able to look at where else we can help with our vaccine supply. We have also put £1.3 billion into a combination of Gavi, the Vaccine Alliance, and COVAX. Of that £1.3 billion, approximately £480 million is going to COVAX, which is helping low and middle-income countries with their vaccination programmes as we speak.